![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Introduction: Exploration of Nab-Paclitaxel in NSCLC (OncLive) View |
![]() |
Nab-Paclitaxel Subgroup Analyses in Non-Small Cell Lung Cancer (OncLive) View |
![]() |
Nab-Paclitaxel plus Carboplatin in Squamous NSCLC (OncLive) View |
![]() |
Debate: The taxane of choice for managing NSCLC is nab-paclitaxel - Agree (HMP Education) View |
![]() |
GI Chemotherapy Education – GA/GemNab: Gemcitabine and Nab-paclitaxel (Abraxane®) (MD Anderson Cancer Center) View |
![]() |
Abraxane for NSCLC (The Healthcare Channel) View |
![]() |
Interview with Dr. Mark A. Socinski, MD (Cancer Therapy Advisor) View |
![]() |
Treating Acquired Resistance to TKIs (OncLive) View |
![]() |
Understanding the Oncology Research and Development Pipeline (Biden Cancer) View |
![]() |
Genetics and Molecular Alterations in Pancreatic Cancer (HMP Education) View |